FDA Investigator Dellarese L Herbert

Dellarese L Herbert has inspections in 4 countries as of 11 Oct 2023. Dellarese L Herbert has collaborated with a combinined 3374 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
136
Last Inspection Date:
11 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Germany, Finland, United Kingdom of Great Britain and Northern Ireland
Co-Investigator(s):
A Williams, Aaron P Wozniak, Abdur Rashid, Abraham M Maekele, Aigbokhai A Dirisu, Alexander M Kay, Allen T Proxmire, Alphonso A Haupt, III, Amanda L Evanco, Amy A Johnson, Ana L Kewes, Angela G Wagley, Annette Melendez, April R Bowen, Arie C Menachem, Arlyss M Jones, Arthur G Hurst, Babatunde D Babalola, Barbara T Carmichael, Benjamin J Dastoli, Bonita S Chester, Brandy D Brown, Brentley S Collins, Brian A Graves, Brian M Campbell, Bruce R Burrell, Calvin Foulks, Camerson E Moore, Cara M Minelli, Carl E Lovrich, Carol F Robinson, Carol J Blackwood, Cesar C Tricoche, Chateryl K Washington, Cherrie A Zachary, Cheryl D Barton, Christie A Beatty, Christie B Rice, Christina H Owens, Christine M O'leary, Christopher B May, Christopher C Wilcox, Claudette D Brooks, Cody D Rickman, Contractor Bridgers, Cordelia J Brammer, Davis, Dawn M Braswell, Debra J Tucker, Dennis R Hudson, Derek C Price, Donald L Zink, Donna Ltartaglino Besone, Doretha M Tonkins, Douglas L Page, Edecia A Richards, Edward D Harris, Edward Deberry, Eileen J Bannerman, Emily A Walters, Emmanuel A Dimaano, Jr, Erika M Wilkerson, Ernest H Blackwood, Esra Toussaint, Ford, Fulton A Varner, Gamal A Norton, Gary E Coleman, Jr, REHS, Gerald Mierle, Geraldine D Sanders, Gideon N Esuzor, Hai Lien T Phung, Heather Akleimola Hulbert, Heather M Wheeler, Helen R Bester, Hristu B Chepa, Ibad U Khan, Igbinoba, Inga M Warr, Ingrid A Zambrana, James P Lewis, Jr, James R Betz, Janet B Gray, Jared P Stevens, Jason F Chancey, Jawaid Hamid, Jessica D Weber, Jessica Fields, Jessica M Simpson, Joan A Loreng, John D Lloyd, John P Shelton, Joseph F Owens, Judy Ellen Ciaraldi, Kara D Miller, Karen A Coleman, Katelynn J Gulya, Katelynn J Rollins, Kathryn A Krentz, Katrina B Mosley Sloan, Kenneth L Smalls, Kenny R Robinson, Kimberly Cdelk Brooks, King, Kip J Hanks, Laiza V Garcia, Lareese K Thomas, Larry K Hampton, Latonya T Jiggetts, Laureen M Geniusz, Lawrence, LCDR Wilfred A Darang, Lesley K Satterwhite, Leslie W Gilbert, Linda S Mattingly, Lorenzo Jones, LT Tamara J Henderson, Mancia R Walker, Marcella D Crook, Marian A Kainer, Marie F Morin, Mark Burns, Marla A Cassidy, Mary A Millner, Mary Alice Papdimitriou, Mary T Carden, Matthew G Brown, Melanie M Walker, Melanie W Pishnery, Miaja Umaedi, Michael P Sweeney, Michelle D Haamid, Michelle L Jones, Mpris Inspector, Myckie M Jacobsen, Myla D Chapman, Myoshi M Francis, Nancy E Fontaine, Nelson A Rodriguez, Nicholas M Smith, Pamela L Vega, Patricia F Hudson, Paul A Bonneau, Paul W Moy, Paula J Bretz, Perry H Gambrell, Phillip M Pontikos, Phyllis Calhoun, Randy L Clarida, Rebecca T Davis, Rhonda Alexander, Richard J Bashay, Richard L Garcia, Richard L Rutherford, Robert W Turner, Robin N Goins, Rocco C Black, Ronnie E Jackson, Russell R Zablan, Samuel L Murray, Sandra C Lawrence, Sandra I Gaul, Sandra R Saunders, Sayeeda Hdabe, Sergio Chavez (NMI), Sheri S Oliver, Sherry R Dunn, Simone M Edmonson, Smith, Song Y Lavalais, Sonya L Karsik, Stardust W Mazzariello, State Agency, Stephanie E Hubbard, Stephanie Harrell, Suyang Qin, T Lindaswart Stewart, Tamara M Casselman, Tamika D Cathey, Tammara A Stephens, Theresa L Stewart, Thomas J Hudson, Tracy R Ball, Trang N Cox, Trang P Nguyen, Travis S Bradley, Tyrico K English, Vanessa E Coulter, Veronica Fuentes, MS, Vincent M Williams, Watson, William S Boivin, Xiomara Copeland, Yung W Chan

Dellarese L Herbert's Documents

Publish Date Document Type Title
March, 2014 FDA 483 Response Artivion, Inc - Form 483R, 2014-04-10
February, 2013 FDA 483 Bausch & Lomb Incorporated - Form 483, 2013-02-08
March, 2014 FDA 483 Artivion, Inc - Form 483, 2014-03-20
April, 2012 FDA 483 Diamond Pet Foods, LLC - Form 483, 2012-04-20
July, 2011 FDA 483 Allwell Medical Corporation - Form 483, 2011-07-20
February, 2015 FDA 483 Sunnex, LLC - Form 483, 2015-02-18
April, 2012 EIR Diamond Pet Foods, LLC - EIR, 2012-04-20
May, 2014 FDA 483 Carolina Surgical Solutions, LLC - Form 483, 2014-05-20
September, 2009 FDA 483 Durden Enterprises, Inc. - Form 483, 2009-09-15

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more